Recombinant ErbB3 (Patritumab Biosimilar) antibody (PE)

Catalog No. ABIN7829145

The PE-conjugated Human Monoclonal anti-ErbB3 (Patritumab Biosimilar) antibody (ABIN7829145) specifically detects ErbB3 (Patritumab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant ErbB3 (Patritumab Biosimilar) antibody (PE) (ABIN7829145)

Target: ErbB3 (Patritumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This ErbB3 (Patritumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-ErbB3 (Patritumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-HER3 (patritumab biosimilar)mAb

Isotype: IgG1, kappa

Application Details

Application Notes: Flow Cyt 1:400

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for ErbB3 (Patritumab Biosimilar)

Target: ErbB3 (Patritumab Biosimilar)

Alternative Name: Patritumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:HER3,ERBB3
Synonyms Antibody:AMG888, U3-1287

UniProt: P21860